Tacrolimus and glucose metabolism.
van Hooff
J P
JP
Department of Internal Medicine, University Hospital Maastricht, The Netherlands. JHO@sint.azm.nl
van Duijnhoven
E M
EM
Christiaans
M H
MH
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D002096:C-Peptide / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D019270:Fructosamine / Q000097:blood; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies; D012044:Regression Analysis; D016559:Tacrolimus / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D001379:Azathioprine; D001786:Blood Glucose; D002096:C-Peptide; D016572:Cyclosporine; D019270:Fructosamine; D005947:Glucose; D006442:Glycated Hemoglobin; D007166:Immunosuppressive Agents; D007328:Insulin; D011241:Prednisone; D016559:Tacrolimus